Clinical

Dataset Information

0

Ensayo clínico para evaluar la respuesta después de cirugía de metastásis hepáticas en cáncer colorrectal en tratamiento con bevacizumab y XELOX.


ABSTRACT: Primary objectives: Correlation between global objectives response according RECIST v1.1 criteria evaluated by conventional images tecniques with morfologic response by TAC and pathologic response after hepatic metastatic resectability. Primary endpoints: Objectives response rate according RECIST v1.1 criteria. Morfologic response rate by TCMD. Pathologic response rate after hepatic metastatic resectability.

DISEASE(S): Patients With Resectable Hepatic Metastasis Secundary To Colorectal Cancer,Pacientes Con Metástasis Hepáticas Resecables Secundarias A Cáncer Colorrectal.,Metastatic Colon Cancer,Patients With Resectable Hepatic Metastasis Secundary To Colorectal Cancer

PROVIDER: 2529162 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2525060 | ecrin-mdr-crc
| EGAS00001003178 | EGA
| 2526593 | ecrin-mdr-crc
| 2539311 | ecrin-mdr-crc
| 2746728 | ecrin-mdr-crc
| 2735605 | ecrin-mdr-crc
| 2117357 | ecrin-mdr-crc
| 2541272 | ecrin-mdr-crc
| 2526016 | ecrin-mdr-crc
| 2519329 | ecrin-mdr-crc